Erasca, Inc. (ERAS): Depreciation & Amortization
$3.11M
Year ended 2025-12-31
$2.94M
Trailing 12 months to 2026-06-30
+5.6%
3-year compound annual growth
+41.9%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $3.11M | -18.3% | 2026-03-12, From 2025-01-01 |
| 2024-12-31 | $3.81M | +2.0% | 2026-03-12, From 2024-01-01 |
| 2023-12-31 | $3.73M | +41.3% | 2025-03-20, From 2023-01-01 |
| 2022-12-31 | $2.64M | +218.6% | 2024-03-27, From 2022-01-01 |
| 2021-12-31 | $829.0K | +53.5% | 2023-03-23, From 2021-01-01 |
| 2020-12-31 | $540.0K | n/a | 2022-03-24, From 2020-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Erasca, Inc. (ERAS) | 2025-12-31 | $3.11M | -18.3% |
| Ironwood Pharmaceuticals Inc (IRWD) | 2025-12-31 | $1.10M | -8.3% |
| Harrow, Inc. (HROW) | 2025-12-31 | $1.92M | +3.5% |
| Nkarta, Inc. (NKTX) | 2025-12-31 | $9.20M | 0.0% |
| Xeris Biopharma Holdings, Inc. (XERS) | 2025-12-31 | $1.31M | +7.0% |
| Alumis Inc. (ALMS) | 2025-12-31 | $3.50M | +10.9% |
| MoonLake Immunotherapeutics (MLTX) | 2025-12-31 | $2.62M | +88.9% |
| Anaptysbio, Inc (ANAB) | 2025-12-31 | $559.0K | -7.8% |
| BGM Group Ltd. (BGM) | 2025-09-30 | $1.46M | +18.3% |
Compare ERAS, IRWD, HROW, NKTX side by side · Screen every company in Pharmaceutical Preparations ↗